Canada 2026 Regulatory Updates: SOR/2026-110, GUI-0016 Version 11 and Fees

1. Key takeaways

The three visible 2026 developments in Canadian device regulation are: SOR/2026-110, which comes into force on 14 December 2026 (phase two of establishment licence modernisation); GUI-0016, version 11, released on 17 June 2026 and also taking effect on 2026-12-14; and the switch of official fees to the new fee-year rates from 1 April 2026.

• SOR/2026-110 was registered on 2026-06-04, published in the Canada Gazette Part II on 2026-06-17, and comes into force on 2026-12-14.
• GUI-0016 version 11 replaces version 10 (dated 2024-12-14); it was released on 2026-06-17 and takes effect on 2026-12-14.
• Health Canada fee pages were published on 2025-12-01 and apply from 2026-04-01; the MDEL fee is 5,519 CAD and the right to sell fee is 460 CAD.
• The Medical Devices Regulations are current to 2026-07-21, with the most recent amendment on 2026-06-17.
• The three developments land on three different layers: the substantive rules of the establishment licence framework, the operational interpretation, and the cost base.
• The roughly half-year gap between the release and the effective date of GUI-0016 is a compliance preparation window, not a grace period.

2. Legal basis

Each of the three developments is traceable to an official document with dates that can be cited precisely. The table below lists them together with the current state of the Regulations themselves.

3. Expert insights

Three changes in one year is a busy cycle for a single market, and each change reaches a different department. The insights below map the three developments onto the layers they affect and onto the work they imply. Taken together, they also show a pattern: the dates are staggered deliberately, and the sequence in which a company responds matters as much as the response itself.

Insight 1: the three developments land on the licence framework, the operational interpretation, and cost respectively.

SOR/2026-110 changes the substantive rules of the establishment licence regime; GUI-0016 version 11 changes the operational interpretation; the annual fee switch changes the cost base. When companies build their annual compliance plan, the first should be mapped to legal and regulatory affairs, the second to the quality department, and the third to finance. Assigning them to the right owners prevents any one of the three from being treated as someone else’s problem.

Insight 2: GUI-0016’s release date and effective date are roughly half a year apart.

GUI-0016 version 11 was released on 2026-06-17 and takes effect on 2026-12-14. This interval is a compliance preparation window, not a grace period — companies should complete their remediation within it, rather than waiting until the effective date to act. Work started after the effective date is, by definition, work done against a standard already in force. A realistic plan treats the release date as the starting gun: gap analysis and drafting in the first half of the window, training and dry runs in the second half.

Insight 3: the fee-year switch date and the ALR deadline coincide on 1 April.

The new fee-year amounts apply from 1 April; the MDEL annual licence review must be completed before 1 April each year. The two 1 April matters can be handled in the same time window, but they are different actions and must be executed separately: one is a payment and budgeting exercise, the other is a licence maintenance filing. Bundling them into a single task obscures who owns which, and the shorter of the two deadlines is the one that will bite.

Insight 4: the amendment cadence of the Regulations themselves is worth tracking continuously.

The Medical Devices Regulations are current to 2026-07-21, with the most recent amendment on 2026-06-17. In the annual compliance review, companies should first check the “current to” date and the “most recently amended” date of the Regulations, and only then cite specific provisions. Citing a provision against a superseded consolidated text is a quiet but recurring failure mode, and it is avoidable at the cost of one look at the Justice Laws current-to banner before every citation.

4. Practical recommendations

• Build a Health Canada page monitoring calendar, focused on GUI-0016, the fee pages, and the “current to” date of the Regulations.
• Plan SOR/2026-110 remediation backwards from the hard deadline of 2026-12-14.
• Complete the documented procedures and supplier information gap-filling within the window from 2026-06-17 to 2026-12-14.
• Handle both the fee switch and the MDEL annual review around 1 April each year, as separate actions in one window.
• Recalculate budgets at the new fee-year rates and reserve headroom for the following year’s increase.
• Record the registration date, Gazette date and effective date of each amendment as three separate data points, so that citing one never substitutes for citing all three.

5. Verification checklist

• □ SOR/2026-110 remediation has been planned backwards from 2026-12-14
• □ The version 11 interpretation of GUI-0016 has been incorporated into internal documents
• □ The 1 April window has been arranged to cover both the fee switch and the ALR
• □ Budgets have been recalculated at the new fee-year rates
• □ The “current to” and “most recently amended” dates of the Regulations have been added to the annual review
• □ A Health Canada page monitoring calendar has been established

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Canadian market. Our team manages Health Canada Medical Device Licence and MDEL applications, prepares risk-classified dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com